Insider Confidence and Penny Stocks
The Dow Jones index closed higher by over 475 points on Wednesday, signaling a positive market sentiment. Insider transactions, where company executives purchase or sell shares, provide a glimpse into their confidence or concerns regarding the company’s future prospects. For investors delving into penny stocks, these moves serve as valuable indicators influencing their trading or investment decisions.
Here’s a peek at some recent significant insider transactions in the realm of penny stocks. For deeper insights, explore Benzinga’s insider transactions platform.
Insider Scoop on Retractable Technologies
- The Deal: Retractable Technologies, Inc. RVP witnessed President and CEO Thomas J Shaw’s acquisition of 5,096 shares at an average price of $1.18, necessitating an investment of about $6,024.
- Recent Event: On November 14, Retractable Technologies disclosed an operational loss of $8.7 million for the initial nine months of 2023.
- Company Profile: Retractable Technologies Inc specializes in designing, developing, manufacturing, and marketing safety syringes and other medical safety products for the healthcare sector.
A Glimpse Into Citizens Inc.
- The Move: Citizens, Inc. CIA‘s Director James Keith Morgan acquired 5,899 shares at an average price of $2.11, with an expenditure of approximately $12,469.
- Recent Development: On March 18, Citizens Inc. appointed Jon Stenberg as the President of Citizens.
- Company Overview: Citizens Inc. operates as an insurance holding company catering to the life insurance requirements of individuals in the United States.
Feast your eyes on this: Walgreens Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
The Insider Move by Journey Medical
- The Play: Journey Medical Corporation DERM saw Director Lindsay A MD Rosenwald acquire 10,000 shares at an average price of $3.04, translating to an insider investment of around $30,400.
- Recent News: On March 21, Journey Medical announced a profit for the fourth quarter.
- Company Focus: Journey Medical Corp operates as a commercial-stage pharmaceutical company concentrating on the development and commercialization of pharmaceutical products for treating dermatological conditions.
Don’t forget to check out our premarket coverage here
